SPARK THERAPEUTICS INC's ticker is ONCE and the CUSIP is 84652J103. A total of 157 filers reported holding SPARK THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 3.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $24,245,000 | +248.2% | 250,000 | +267.6% | 1.61% | +266.1% |
Q2 2019 | $6,962,000 | -44.0% | 68,000 | -70.2% | 0.44% | -41.2% |
Q3 2018 | $12,437,000 | +0.2% | 228,000 | +52.0% | 0.75% | -7.9% |
Q2 2018 | $12,414,000 | +3.6% | 150,000 | -16.7% | 0.81% | -11.6% |
Q1 2018 | $11,986,000 | – | 180,000 | – | 0.92% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 170,000 | $5,017,000 | 5.76% |
Rock Springs Capital Management LP | 580,500 | $17,131,000 | 1.44% |
Opus Point Partners Management, LLC | 31,500 | $930,000 | 0.72% |
Bain Capital Public Equity Management, LLC | 424,114 | $12,516,000 | 0.46% |
Baker Brothers Advisors | 1,262,382 | $37,253,000 | 0.39% |
MARINER INVESTMENT GROUP LLC | 34,350 | $1,014,000 | 0.28% |
Eventide Asset Management | 150,000 | $4,427,000 | 0.25% |
Virtus ETF Advisers LLC | 5,251 | $155,000 | 0.21% |
EMERALD ADVISERS, LLC | 123,970 | $3,658,000 | 0.18% |
Endurant Capital Management LP | 17,500 | $516,000 | 0.17% |